【碧迪医疗据悉拟分拆生命科学部门,对后者估值或达近300亿美元】2月3日消息,知情人士称,美国碧迪医疗考虑分拆生命科学部门,对后者估值可能达到近300亿美元。据悉,碧迪医疗可能选择保留标本管理业务。知情人士透露,该公司或于当地时间2月6日发布收益报告时宣布分拆计划。

金融界
03 Feb
2月3日消息,知情人士称,美国碧迪医疗考虑分拆生命科学部门,对后者估值可能达到近300亿美元。据悉,碧迪医疗可能选择保留标本管理业务。知情人士透露,该公司或于当地时间2月6日发布收益报告时宣布分拆计划。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10